Author

Catherine E. Kuzmicki

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alex MabryiD· 1 shared Angelina O’Brien· 1 shared Jason D. WeberiD· 1 shared Leonard B. MaggiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alex MabryORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Elevated type I interferon signaling defines the proliferative advantage of ARF and p53 mutant tumor cells

Alex Mabry, Catherine E. Kuzmicki, Angelina O’Brien, Leonard B. Maggi, Jason D. Weber

The paper shows that loss of p53 and ARF increases type I interferon signaling, which drives proliferation and is inhibited by JAK1 inhibitors in tumor cells.

Molecular and Cellular Biology · May 12, 2025Peer-reviewedCancer Biology